↓ Skip to main content

Prospective adherence to specific immunotherapy in Europe (PASTE) survey protocol

Overview of attention for article published in Clinical and Translational Allergy, April 2015
Altmetric Badge

Mentioned by

facebook
1 Facebook page

Citations

dimensions_citation
6 Dimensions

Readers on

mendeley
19 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Prospective adherence to specific immunotherapy in Europe (PASTE) survey protocol
Published in
Clinical and Translational Allergy, April 2015
DOI 10.1186/s13601-015-0060-0
Pubmed ID
Authors

Melina Makatsori, Gianenrico Senna, Constantinos Pitsios, Ramon Lleonart, Ludger Klimek, Carlos Nunes, Maia Rukhadze, Barbara Rogala, Radoslaw Gawlik, Petr Panzner, Oliver Pfaar, Moises Calderon

Abstract

Adherence to allergen immunotherapy is important for its effectiveness. There is currently limited data available on allergen immunotherapy adherence outside of clinical trials i.e. in real-life clinical practice. As part of a European Academy of Allergy and Clinical Immunology Immunotherapy Interest group initiative, we endeavoured to design a survey in order to prospectively evaluate adherence to subcutaneous and sublingual immunotherapy across different European countries. The inclusion criteria for this prospective, multi-country survey were set as: adults, starting clinically indicated allergen immunotherapy for respiratory allergic disorders or Hymenoptera venom allergy. An online survey was designed in order to enrol participants and assess adherence to immunotherapy. Eight countries (Czech Republic, Georgia, Germany, Greece, Italy, Poland, Portugal, Spain) were selected to reflect different parts of Europe and differences in allergens and routes of immunotherapy administration. Each country has an allocated National co-ordinator that has identified local Allergy departments willing to enrol participants in this survey. Each participant will be followed up for a total of three years. In order to assess adherence, a 4-monthly follow-up form detailing any missed doses and reasons will be completed online. In case of a participant discontinuing treatment, reasons for this will be recorded. The use of online survey software has enabled us to make this survey a reality and reach clinicians in different countries. Forty-five centres have enrolled a total of over 1,350 participants. It is hoped that this prospective real life survey will enable us to gain a better understanding of reasons that affect adherence to subcutaneous and sublingual immunotherapy and assist in developing ways to improve this.

Mendeley readers

The data shown below were compiled from readership statistics for 19 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Indonesia 1 5%
Unknown 18 95%

Demographic breakdown

Readers by professional status Count As %
Other 5 26%
Researcher 4 21%
Student > Ph. D. Student 3 16%
Student > Master 2 11%
Lecturer 1 5%
Other 1 5%
Unknown 3 16%
Readers by discipline Count As %
Medicine and Dentistry 7 37%
Agricultural and Biological Sciences 2 11%
Unspecified 1 5%
Business, Management and Accounting 1 5%
Arts and Humanities 1 5%
Other 3 16%
Unknown 4 21%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 October 2015.
All research outputs
#15,056,212
of 17,039,068 outputs
Outputs from Clinical and Translational Allergy
#477
of 508 outputs
Outputs of similar age
#196,777
of 239,468 outputs
Outputs of similar age from Clinical and Translational Allergy
#1
of 1 outputs
Altmetric has tracked 17,039,068 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 508 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.7. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 239,468 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them